These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 11684954)
21. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209 [TBL] [Abstract][Full Text] [Related]
22. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Bayrak R; Haltas H; Yenidunya S Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990 [TBL] [Abstract][Full Text] [Related]
23. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer. Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736 [TBL] [Abstract][Full Text] [Related]
24. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. McKenney JK; Desai S; Cohen C; Amin MB Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293 [TBL] [Abstract][Full Text] [Related]
25. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
26. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. Bayrak R; Yenidünya S; Haltas H Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma. Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Lane Z; Hansel DE; Epstein JI Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358 [TBL] [Abstract][Full Text] [Related]
29. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Inamura K; Satoh Y; Okumura S; Nakagawa K; Tsuchiya E; Fukayama M; Ishikawa Y Am J Surg Pathol; 2005 May; 29(5):660-5. PubMed ID: 15832091 [TBL] [Abstract][Full Text] [Related]
31. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Chen ZM; Wang HL Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952 [TBL] [Abstract][Full Text] [Related]
32. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340 [TBL] [Abstract][Full Text] [Related]
33. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652 [TBL] [Abstract][Full Text] [Related]
34. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Jiang J; Ulbright TM; Younger C; Sanchez K; Bostwick DG; Koch MO; Eble JN; Cheng L Arch Pathol Lab Med; 2001 Jul; 125(7):921-3. PubMed ID: 11419977 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878 [TBL] [Abstract][Full Text] [Related]
36. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma. Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164 [TBL] [Abstract][Full Text] [Related]
37. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy. Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107 [TBL] [Abstract][Full Text] [Related]
38. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases. Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786 [TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2]. Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Wong SC; Lo ES; Lee KC; Chan JK; Hsiao WL Clin Cancer Res; 2004 Feb; 10(4):1401-8. PubMed ID: 14977843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]